- Formula
- C₁₅H₂₁NO₂
1
- C₁₅H₂₁NO₂
- Mass
- 247.1572 Da
1
- 247.1572 Da
Overview
Chemistry
All data
223 statements · 68% with external sources · numbers in brackets are citations
- Significant drug interaction
- isocarboxazid
- phenelzine
- procarbazine
- (±)-deprenyl
- tranylcypromine
- phenelzine side effect: depressed level of consciousness
- tramadol side effect: depressed level of consciousness
- tramadol side effect: central respiratory depression
Show 52 moreShow less
- (RS)-methadone side effect: depressed level of consciousness
- (RS)-methadone side effect: central respiratory depression
- morphine side effect: depressed level of consciousness
- morphine side effect: central respiratory depression
- oxycodone side effect: depressed level of consciousness
- oxycodone side effect: central respiratory depression
- hydromorphone side effect: depressed level of consciousness
- hydromorphone side effect: central respiratory depression
- dihydrocodeine side effect: depressed level of consciousness
- dihydrocodeine side effect: central respiratory depression
- codeine side effect: depressed level of consciousness
- codeine side effect: central respiratory depression
- remifentanil side effect: depressed level of consciousness
- remifentanil side effect: central respiratory depression
- tapentadol side effect: depressed level of consciousness
- tapentadol side effect: central respiratory depression
- alfentanil side effect: depressed level of consciousness
- alfentanil side effect: central respiratory depression
- sufentanil side effect: depressed level of consciousness
- sufentanil side effect: central respiratory depression
- fentanyl side effect: depressed level of consciousness
- fentanyl side effect: central respiratory depression
- (±)-promethazine side effect: depressed level of consciousness
- (±)-promethazine side effect: central respiratory depression
- levomepromazine side effect: depressed level of consciousness
- levomepromazine side effect: central respiratory depression
- fluphenazine side effect: depressed level of consciousness
- fluphenazine side effect: central respiratory depression
- chlorpromazine side effect: depressed level of consciousness
- chlorpromazine side effect: central respiratory depression
- chlorpheniramine side effect: paralytic ileus
- paroxetine side effect: paralytic ileus
- imipramine side effect: paralytic ileus
- clomipramine side effect: paralytic ileus
- linezolid side effect: toxicity
- moclobemide side effect: toxicity
- rasagiline side effect: toxicity
- phenelzine side effect: toxicity
- (−)-selegiline side effect: toxicity
- trimeprazine side effect: depressed level of consciousness
- trimeprazine side effect: central respiratory depression
- nitrazepam side effect: depressed level of consciousness
- nitrazepam side effect: central respiratory depression
- zopiclone side effect: depressed level of consciousness
- zopiclone side effect: central respiratory depression
- clobazam side effect: depressed level of consciousness
- clobazam side effect: central respiratory depression
- dexmedetomidine side effect: depressed level of consciousness
- dexmedetomidine side effect: central respiratory depression
- (RS)-sulpiride side effect: depressed level of consciousness
- (RS)-sulpiride side effect: central respiratory depression
- perampanel side effect: depressed level of consciousness
- Canonical SMILES
- CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
1
- CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
- MCN code
- 2933.33.81
- Physically interacts with
- Opioid receptor delta 1 subject has role: agonist
1
- opioid receptor kappa 1 subject has role: agonist
1
- opioid receptor mu 1 subject has role: agonist
1
- Opioid receptor delta 1 subject has role: agonist
- Discovered by
- Otto Eisleb discovered: 1939
- Substance control status
- Schedule 8 (Australia) applies to jurisdiction: Australia
- Schedule I (Canada) applies to jurisdiction: Canada
- Anlage III (Germany) applies to jurisdiction: Germany
- Class A (United Kingdom) applies to jurisdiction: United Kingdom
- Schedule II (United States) applies to jurisdiction: United States
- Schedule I (Single Convention 1961)
On other databases
53 identifiers linking pethidine across the web's reference databases
- ATC codeN02AB02
- Brockhaus Enzyklopädie online IDpethidin
- CAS Registry Number57-42-1
- ChEBI ID6754
- ChEMBL IDCHEMBL607
- ChemSpider ID3918
- DrugBank IDDB00454
- DrugCentral ID1690
- DSSTOX compound identifierDTXCID403253
- DSSTox substance IDDTXSID9023253
- EC number200-329-1
- ECHA Substance Infocard ID100.000.299
- Encyclopædia Britannica Online IDscience/meperidine
- Encyclopedia of China (Third Edition) ID (2026)2I5G8H
- Encyclopedia of China (Third Edition) old ID (2021)141479
- Freebase ID/m/02x3hw
- Gran Enciclopèdia Catalana IDpetidina
- Gran Enciclopèdia Catalana ID (former scheme)0131557
- Guide to Pharmacology Ligand ID7221
- Hrvatska enciklopedija ID47879
- HSDB ID3116
- Human Metabolome Database IDHMDB0014597
- IEDB Epitope ID549276
- InChIInChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
- InChIKeyXADCESSVHJOZHK-UHFFFAOYSA-N
- KEGG IDC07128
- Library of Congress Authorities IDsh85068655
- MassBank accession IDMSBNK-Eawag-EQ333101
- MedlinePlus drug identifiera682117
- MeSH concept IDM0013427
- MeSH descriptor IDD008614
- MeSH tree codeD03.066.399.450
- Microsoft Academic ID (discontinued)2781168792
- NALT ID8458
- National Library of Spain SpMaBN IDXX544571
- NDF-RT IDN0000147902
- NE.se IDpetidin
- OpenAlex IDC2781168792
- PatientsLikeMe treatment IDmeperidine-pethidine
- Probes And Drugs IDPD010019
- Proleksis enciklopedija ID41518
- PubChem CID4058
- Quora topic IDMeperidine
- Römpp online IDRD-16-01265
- RxNorm CUI6754
- SPLASHsplash10-0002-0190000000-96507adebcd15f1cb917
- Store medisinske leksikon IDpetidin
- SureChEMBL ID25431
- UK Parliament thesaurus ID512252
- UMLS CUIC0025376
- UniChem compound ID582956
- UNII9E338QE28F
- WikiProjectMed IDPethidine